Spondylitis Stocks List

Spondylitis Stocks Recent News

Date Stock Title
Nov 21 MLTX MoonLake Immunotherapeutics: A Somewhat Complicated Story
Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
Nov 19 ABBV Where Will AbbVie Be in 5 Years?
Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
Nov 19 ABBV RVPH: Year-End OLE Update
Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
Nov 18 ABBV AbbVie snaps eight straight sessions of losses
Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
Nov 18 ABBV AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe
Nov 18 ABBV Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products
Nov 18 ABBV AbbVie’s Elahere wins European approval for certain ovarian cancers
Nov 18 ABBV Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
Nov 18 ABBV AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer
Nov 17 ABBV Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
Nov 17 ABBV AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 16 ABBV Why AbbVie’s (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment
Nov 15 ABBV Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback
Nov 15 ABBV U.S. Pharma is largely immune from 'MAHA' impact: Wolfe
Nov 15 ABBV AbbVie Stock Falls 11% in a Month: Should You Buy the Dip?
Nov 15 ABBV AbbVie, Bitcoin And An Energy Stock On CNBC's 'Final Trades'
Spondylitis

Spondylitis is an inflammation of the vertebrae. It is a form of spondylopathy. In many cases, spondylitis involves one or more vertebral joints, as well, which itself is called spondylarthritis.

Browse All Tags